Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 May 26;30(1):71.
doi: 10.1186/s10020-024-00824-9.

An update on chronic complications of diabetes mellitus: from molecular mechanisms to therapeutic strategies with a focus on metabolic memory

Affiliations
Review

An update on chronic complications of diabetes mellitus: from molecular mechanisms to therapeutic strategies with a focus on metabolic memory

Tongyue Yang et al. Mol Med. .

Abstract

Diabetes mellitus, a chronic metabolic disease, often leads to numerous chronic complications, significantly contributing to global morbidity and mortality rates. High glucose levels trigger epigenetic modifications linked to pathophysiological processes like inflammation, immunity, oxidative stress, mitochondrial dysfunction, senescence and various kinds of cell death. Despite glycemic control, transient hyperglycemia can persistently harm organs, tissues, and cells, a latent effect termed "metabolic memory" that contributes to chronic diabetic complications. Understanding metabolic memory's mechanisms could offer a new approach to mitigating these complications. However, key molecules and networks underlying metabolic memory remain incompletely understood. This review traces the history of metabolic memory research, highlights its key features, discusses recent molecules involved in its mechanisms, and summarizes confirmed and potential therapeutic compounds. Additionally, we outline in vitro and in vivo models of metabolic memory. We hope this work will inform future research on metabolic memory's regulatory mechanisms and facilitate the development of effective therapeutic compounds to prevent diabetic complications.

Keywords: Diabetic complications; Metabolic memory; Models of metabolic memory; Molecular mechanisms; Treatment progress.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest that pertain to this work.

Figures

Fig. 1
Fig. 1
Overview of metabolic memory. A Chronological depiction of key events in the development of metabolic memory. B, C Bibliometric analysis exploring the intersection of metabolic memory and diabetic complications. Search criteria were set as follows: TS = ((“metabolic memory” OR “hyperglycemic memory”) AND (“diabetes” OR “diabetic”)) with a date range of DOP = (2013–08-01/2023–08-01). B Illustration of the annual trend in the number of published articles. C Clustered view of the key terms and concepts emerging from the literature
Fig. 2
Fig. 2
Key molecular mechanisms of metabolic memory. Despite the normalization of glucose levels, epigenetic modifications, inflammatory and immune responses, oxidative stress, mitochondrial dysfunction, cellular senescence, and apoptosis persist. These processes constitute the core molecular mechanisms underlying metabolic memory. ncRNAs noncoding RNAs, TXNIP thioredoxin-interacting protein, me-TXNIP thioredoxin-interacting protein, IL-6 interleukin-6, MCP-1 monocyte chemotactic protein 1, H3K9me3 trimethylated histone H3 at lysine 9, ROS reactive oxygen species
Fig. 3
Fig. 3
Metabolic memory and chronic complications of diabetes. Hyperglycemia can trigger a range of diabetic complications, including diabetic cardiomyopathy, diabetic arterial vascular disease, diabetic kidney disease, diabetic retinopathy, and diabetic foot. This figure illustrates the intricate relationship between metabolic memory and these chronic conditions

References

    1. Aboouf MA, et al. Genotype screening of APLN rs3115757 variant in Egyptian women population reveals an association with obesity and insulin resistance. Diabetes Res Clin Pract. 2015;109(1):40–47. doi: 10.1016/j.diabres.2015.05.016. - DOI - PubMed
    1. Acosta JB, et al. The pro-inflammatory environment in recalcitrant diabetic foot wounds. Int Wound J. 2008;5(4):530–539. doi: 10.1111/j.1742-481X.2008.00457.x. - DOI - PMC - PubMed
    1. Afonso AC, et al. Biofilms in diabetic foot ulcers: impact, risk factors and control strategies. Int J Mol Sci 2021;22(15). - PMC - PubMed
    1. Aiello LP, D.E.R. Group (2014) Diabetic retinopathy and other ocular findings in the diabetes control and complications trial/epidemiology of diabetes interventions and complications study. Diabetes Care 37(1): 17–23 - PMC - PubMed
    1. Al-Dabet MM, et al. Reversal of the renal hyperglycemic memory in diabetic kidney disease by targeting sustained tubular p21 expression. Nat Commun. 2022;13(1):5062. doi: 10.1038/s41467-022-32477-9. - DOI - PMC - PubMed